111 Capital’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$237K Buy
+3,660
New +$267K 0.04% 476

Other funds holding PTCT

111 Capital's PTCT Position: Q3 2026 in Review

111 Capital opened a new position in PTC Therapeutics (PTCT) in Q3 2026: 3,660 shares worth $237K. The stake represents 0.04% of the portfolio and ranks #476 among its holdings.

361 funds tracked by Wall St. Rank hold PTCT as of Q3 2026.

  • 111 Capital held 3,660 shares of PTC Therapeutics worth $237K as of Q3 2026.
  • PTC Therapeutics was a new 111 Capital position in Q3 2026.
  • PTC Therapeutics made up 0.04% of 111 Capital's portfolio in Q3 2026, its #476 holding.
  • 361 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2026.

Based on 111 Capital's 13F filing for Q3 2026, filed 3 Nov 2026.